Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope Orange County, posted on LinkedIn:
“ASCO25 Continuing with the immunotherapy promise for the subset of patients with NO active LIVER METASTASES NLM MSS colorectal cancer, see this.
ADG126 Masked CTLA4 + Pembro
ORR ~ 29% Sustained.
FRUQ + Immunotherapy arm.”
Read OncoDaily’s Special Articles about ASCO 2025:
Highlights from ASCO 2025 Day 1